Professional Documents
Culture Documents
A Review On Chemical Constituents and Bioactivities of Viburnum Odoratissimum
A Review On Chemical Constituents and Bioactivities of Viburnum Odoratissimum
Review
Abstract
Viburnum odoratissimum belongs to viburnum genus of the Caprifoliaceae family. Previous studies reported many chemical
constituents in this plant, including monoterpenoids, sesquiterpenoids, vibsane-type diterpenes, triterpenes, coumarins, and
lignans, and various pharmacological bioactivities the extracts of V. odoratissimum such as anti-tumor, neuroprotective, anti-
inflammatory, ichthyism and anti-oxidant activity. Besides, the total synthesis of vibsane-type diterpenes and their derivatives
have attracted considerable attention because of their wide-ranging anti-tumor activity. This present study not only systematically
summarizes the compounds isolated from V. odoratissimum, and the structure-activity relationship of these compounds.
263
A review on chemical constituents and bioactivities of Viburnum odoratissimum / Asian
Journal of Traditional Medicines, 2020, 15(5)
264
A review on chemical constituents and bioactivities of Viburnum odoratissimum / Asian
Journal of Traditional Medicines, 2020, 15(5)
Vibsane-type diterpenes are quite rare natural It was reported that 43 7-membered
products, existing only in some species of Viburnum ring type diterpenes were obtained, and their
genus [6]. Diterpenes from this plant can be structures were identified as vibsanin C (37),
categorized into 11-membered ring, 7-membered vibsanin G (38), vibsanin I (39), vibsanin H (40),
ring and rearranged types. vibsanin K (41), (14S*)-14,15-epoxyvibsanin
C (42), vibsanin W (43), dehydrovibsanin
2.3.1 11-membered ring G (44), 15,18-di-O-methylvibsanin H (45),
18-O-methylvibsanin K (46), 18-O-methylvibsanin
At present, 26 11-membered ring type vibsane- G (47), 18-O-methylvibsanin C (48), cyclovibsanin
type diterpenes have been isolated, including A (49), 15-O-methylcyclovibsanin A (50),
vibsanin F (11), 14-hydroxyVibsanin F (12), vibsanin 15-O-methylcyclovibsanin B (51), 3-hydroxy-15-O-
V (13), vibsanin H (14), vibsanin B (15), vibsanol methylcyclovibsanin A (52), 5-epivibsanin C (53),
A (16), vibsanol B (17), vibsanin U (18), vibsanin 5-epivibsanin G (54), (14R*)-14,15-epoxyvibsanin
A (19), vibsanin P (20), vibsanin Q (21), vibsanin C (55), 5-epivibsanin H (56), 5-epivibsanin K (57),
L (22), vibsanin E (23), vibsanol G (24), vibsanin 3-hydroxyvibsanin E (58), 5-epivibsanin E (59),
D (25), vibsanol F (26), 15-O-methylvibsanin U furanovibsanin A (60), 3-O-methylfuranovibsanin A
(27), 15,18-O-diacetyl-15-O-methylvibsanin U (61), furanovibsanin B (62), 7-epifuranovibsanin B
(28),vibsanin R (29), vibsanin S (30), vibsanol C (63), 7-epialdovibsanin A (64), aldovibsanin A (65),
(31), vibsanin X (32), vibsanin T (33), 6-O-methyl- aldovibsanin B (66), aldovibsanin C (67), vibsanin
6,7-dihydroxyvibsanin B (34), 4-hydroxyvibsanin A D (68), vibsaniguration A (69), 18-O-methyl-5-
(35), and vibsanum A (36) [7-12]. (Fig. 3) epivibsanin K (70), vibsanin M (71), vibsanin E
265
A review on chemical constituents and bioactivities of Viburnum odoratissimum / Asian
Journal of Traditional Medicines, 2020, 15(5)
(to be continued)
266
A review on chemical constituents and bioactivities of Viburnum odoratissimum / Asian
Journal of Traditional Medicines, 2020, 15(5)
Continued fig. 3
(to be continued)
267
A review on chemical constituents and bioactivities of Viburnum odoratissimum / Asian
Journal of Traditional Medicines, 2020, 15(5)
Continued fig. 3
(to be continued)
268
A review on chemical constituents and bioactivities of Viburnum odoratissimum / Asian
Journal of Traditional Medicines, 2020, 15(5)
Continued fig. 3
(to be continued)
269
A review on chemical constituents and bioactivities of Viburnum odoratissimum / Asian
Journal of Traditional Medicines, 2020, 15(5)
Continued fig. 3
270
A review on chemical constituents and bioactivities of Viburnum odoratissimum / Asian
Journal of Traditional Medicines, 2020, 15(5)
(to be continued)
271
A review on chemical constituents and bioactivities of Viburnum odoratissimum / Asian
Journal of Traditional Medicines, 2020, 15(5)
Continued fig. 4
(to be continued)
272
A review on chemical constituents and bioactivities of Viburnum odoratissimum / Asian
Journal of Traditional Medicines, 2020, 15(5)
Continued fig. 4
273
A review on chemical constituents and bioactivities of Viburnum odoratissimum / Asian
Journal of Traditional Medicines, 2020, 15(5)
274
A review on chemical constituents and bioactivities of Viburnum odoratissimum / Asian
Journal of Traditional Medicines, 2020, 15(5)
275
A review on chemical constituents and bioactivities of Viburnum odoratissimum / Asian
Journal of Traditional Medicines, 2020, 15(5)
E (23) and 5-epi-vibsanin E (59). In addition, Yoshiyasu Fukuyama et al. found vibsanin E (23)
Williams group completed the synthesis of could be derived from vibsanin C (37) [41].
(±)-2-O-methylneovibsanin H (80). Based on the
synthetic route of 2-O-methylneovibsanin H (80), 3.2 The structural modifications of vibsane-type
they also synthesized 14-epi-neovibsanin G (94) and diterpenoids
neovibsanin G (95) with the same structure [39].
Neovibsanins A (84) and B (85) exhibited good More importantly, in addition to the synthesis
biological activities. At concentrations ranging of vibsane-type diterpenoids, derivatives of this type
from 20 to 40 µM, neovibsanins A (84) and B were also obtained by structural modification.
(85) significantly promoted the neurite outgrowth Compounds vibsanin A (19), analog A (153)
of NGF-mediated PC12 cells [40]. Imagawa and and analog B (154) were produced as synthetic
Nishizawa completed the first total synthesis of intermediates during the synthesis of compounds.
neovibsanin B (85). Fukuyama group investigated a Vibsanin A (19) and analog B (154) were oxidized
method that demonstrated the formal enantioselective to give obtained analog D (156) and analog C (155),
synthesis of (+)-neovibsanin B (85) [39]. respectively [42]. (Fig. 8)
Besides, 54 vibsanin B derivatives were also (168), vibsanin B-15 (169), vibsanin B-16 (170),
obtained by structural modifications, including vibsanin B-17 (171), vibsanin B-18 (172), vibsanin
vibsanin B-7 (157), vibsanin B-8 (158), vibsanin B-19 (173), vibsanin B-8a (174), vibsanin B-8b
B-11 (159), vibsanin B-12a (160), vibsanin B-12b (175), vibsanin B-8c (176), vibsanin B-8d (177),
(161), vibsanin B-12c (162), vibsanin B-12d (163), vibsanin B-8e (178), vibsanin B-27b (179), vibsanin
vibsanin B-12e (164), vibsanin B-12f (165), vibsanin B-27c (180), vibsanin B-27d (181), vibsanin
B-13a (166), vibsanin B-13b (167), vibsanin B-13c B-27e (182), vibsanin B-27f (183), vibsanin B-28b
276
A review on chemical constituents and bioactivities of Viburnum odoratissimum / Asian
Journal of Traditional Medicines, 2020, 15(5)
(184), vibsanin B-28c (185), vibsanin B-28d (186), (200), vibsanin B-25c (201), vibsanin B-26b (202),
vibsanin B-28e (187), vibsanin B-28f (188), vibsanin vibsanin B-26c (203), vibsanin B-29b (204),
B-24a (189), vibsanin B-24b (190), vibsanin B-24c vibsanin B-29c (205), vibsanin B-9 (206), vibsanin
(191), vibsanin B-24d (192), vibsanin B-24e (193), B-10 (207), vibsanin B-14 (208), vibsanin B-8f
vibsanin B-24f (194), vibsanin B-23a (195), vibsanin (209), vibsanin B-22 (210), and vibsanin B-21
B-23b (196), vibsanin B-23c (197), vibsanin B-20a (211) [43]. (Fig. 9)
(198), vibsanin B-20b (199), vibsanin B-25b
277
A review on chemical constituents and bioactivities of Viburnum odoratissimum / Asian
Journal of Traditional Medicines, 2020, 15(5)
Continued fig. 9
278
A review on chemical constituents and bioactivities of Viburnum odoratissimum / Asian
Journal of Traditional Medicines, 2020, 15(5)
Vibsanol C (31) exhibited stronger inhibitory IC50 values of 1.12 ± 0.15, 0.76 ± 0.44, 2.26 ± 0.10,
activity against all the tested cell lines HL-60, 0.86 ± 0.06, 0.86 ± 0.06, 0.59 ± 0.10, 2.64 ± 0.72,
SMMC-7721, A-549, MCF-7 and SW-480, with and 2.84 ± 0.13 µM, respectively [43].
IC50 values of 3.35, 4.41, 5.18, 11.30 and 3.70 µM. 5-Epi-vibsanin G (54), vibsanol A (16) and
Vibsanol F (26) and vibsanol G (24) also showed 6β-hydroxylup-20(29)-en-3-oxo-27,28-dioic acid
strong inhibitory activity against SMMC-7721 (102) were isolated from the leaves and flowers of
cell line, with IC 50 values of 3.69 and 3.52 µM, V. odoratissimum. Remarkably, 5-epi-vibsanin G
respectively [9]. Remarkably, vibsanin K (41) (54) was evaluated to have a weak inhibitory effect
was identified as a Hsp90 inhibitor and showed against NUGC cells [14]. Comparatively, vibsanol
significant cytotoxicity against HL-60 cell line A (16) and 6β-hydroxylup-20(29)-en-3-oxo-27,28-
with an IC 50 value of 19.16 µM. In addition, dioic acid (102) showed obvious cytotoxicity against
15,18-O-diacetyl-15-Omethylvibsanin U (28) NUGC tumor cells with IC 50 values of 3.00 and
displayed significant inhibitory effects HL-60, A-549, 4.00 µM, respectively [10].
SMMC-7721, MCF-7 and SW480 cell lines, with In addition, the anti-tumor effect of MeOH
IC50 values of 0.15 ± 0.01, 0.69 ± 0.01, 0.41 ± 0.02, extracts from leaves and twigs of V. odoratissimum
0.75 ± 0.03, and 0.48 ± 0.03 µM, respectively [36]. and V. awabuki were investigated. Vibsanin P (20)
These compounds were isolated from the leaves and exhibited moderate inhibitory activity against A549
twigs of V. odoratissimum. and HT-29 cell lines with IC50 values of 11.05 and
Dehydrovibsanin G (44) and (+)-9’-O-senecioyl- 13.39 µM respectively. Vibsanin W (43) had similar
lariciresinol (137) were also isolated and identified effects on the two cells with IC50 values of 22.20 and
from the leaves and twigs of the V. odoratissimum. 18.15 µM, respectively. These compounds displayed
Most of them have good inhibitory effects on skin excellent cytotoxicity against P-388 cell lines with
and breast cancer. Dehydrovibsanin G (44) was IC50 values of 5.38 and 4.85 µM, respectively [7].
found to exhibit significant cytotoxicity against Besides, vibsanin O (78) also exhibited cytotoxicity
A431 and T47D cell lines by sulforhodamine against P-388 cell with an IC50 value of 8.25 µM [19].
B (SRB) method, with IC 50 values of 20.60 and At the same time, 3β-hydroxyolean-12-en-28-
15.60 µM. While (+)-9’-O-senecioyllariciresinol oic acid (106) and 3β,20-dihydroxy lupane-28-oic
(137) exhibited moderate inhibition against acid (107) were isolated and identified. The two
these two cell lines with IC50 values of 33.80 and compounds cytotoxicity against P388 and HT29
44.80 µM, respectively [12]. cell lines, with IC50 values of 14.31 and 77.09 µM,
Moreover, vibsanin B (15) and vibsanin for the first compound and IC50 values of 18.94 and
C (37) were also isolated from the leaves of 61.05 µM, for the second [28].
V. odoratissimum. Their cytotoxicity against KB Meanwhile, the cytotoxicy of compounds
cell lines was evaluated, with IC50 values of 3.50 lupeol (113) and 3-acetoxyolean-12-en-28-ol (127),
and 11.30 µM, respectively. 5-epi-vibsanin C (53) extracted from V. odoratissimum, to SMMC-7721,
and 5-epi-vibsanin H (56) also showed cytotoxicity HeLa, and K562 cell lines were studied by using
against KB cell lines, with IC50 values of 10.70 and the MTT assay. Compound lupeol (113) showed
45.50 µM, respectively [13,15]. In addition, anti- significant cytotoxic activity against SMMC-
tumor activity of vibsanin B-12f (165) against SK- 7721 and HeLa cells, with IC 50 values of 55.32
BR-3, MDA-MB-468, HepG2, AGS, Huh-7, HeLa, and 46.59 µM, respectively, while the compound
BT474 and BEAS-2B cell lines was also tested, with 3-acetoxyolean-12-en-28-ol (127) displayed
279
A review on chemical constituents and bioactivities of Viburnum odoratissimum / Asian
Journal of Traditional Medicines, 2020, 15(5)
moderate inhibitory effect against K562 cells with messages, including the positive control, cell lines,
an IC50 value of 37.68 µM [44]. To make the results time and IC50 value (Table 1).
more intuitive, we use a table to describe these
(to be continued)
280
A review on chemical constituents and bioactivities of Viburnum odoratissimum / Asian
Journal of Traditional Medicines, 2020, 15(5)
Continued table 1
Compounds Positive control Cell lines Time/h IC50/µM
3β,20-dihydroxy lupane-28-oic acid P388 72 h 18.94
HT-29 144 h 61.05
lupeol SMMC-7721 55.32
HeLa 46.59
3-acetoxyolean-12-en-28-ol K562 37.68
vibsanin B-12f SK-BR-3 1.12
MDA-MB-468 0.76
HepG2 2.26
AGS 0.86
cisplatin 48 h
Huh-7 0.86
Hela 0.59
BT474 2.64
BEAS-2B 2.84
Note: Different colors represent different compounds.
Recently, modern pharmacological surveys kinase inhibitors (TKIs) could induce differentiation
indicated that vibsane-type diterpenoids had novel of AML cells; and the combination of vibsanin A (19)
biological activities. For example, vibsanin A (19), and TKIs could activate PKC, upregulate of Lyn,
a promising new antileukemic lead, was reported activate MAPK signaling pathway, and has induced
to inhibit acute myeloid leukemia (AML); Tyrosine tumor cells differentiation [45,46]. (Fig. 10)
Vibsanin A analog C (155) had extensive anti- biology experiments, molecular docking and
proliferative activity against various cancer cell structure−activity relationships (SARs) demonstrated
lines, and the underlying mechanism was related that vibsanin B (15) could directly combine with
to the inhibition of Hsp90 [50]. Multiple molecular Hsp90 C-terminus. Vibsanin B-12f (165), one of
281
A review on chemical constituents and bioactivities of Viburnum odoratissimum / Asian
Journal of Traditional Medicines, 2020, 15(5)
the vibsanin B derivatives, was also proven to be compounds with vibsanin B (15) scaffolds were
Hsp90 C-terminus inhibitor since, it could decrease considered potential anticancer agents. It’s anti-
the expression of Hsp90 client proteins, including cancer mechanism could be related to the inhibition
c-Raf, Her2, p-Akt, and CDK4. Besides, it could of Hsp90 activities [42]. (Fig. 11)
also lead to G2/M cell cycle arrest. Hence, some
Meanwhile, it was reported that vibsanol the proteins of PI3K/AKT signaling pathway [45].
A (16) could inhibit AML, but unlike vibsanin A (Fig. 13)
(19), it caused cell cycle arrest. It also induced cell
differentiation via controlling protein kinase C (PKC) 4.2 Neuroprotective
and downregulating the extracellular signal regulated
kinase (ERK) pathway. Besides, reactive oxygen Recently, the extracts from the dry leaves
species (ROS) levels also played an important role of V. odoratissimum have been shown to have
in the treatment of AML. In conclusion, vibsanol A neuroprotective effects. Two new iridoids were
(16), a differentiation agent against AML, inhibited isolated and identified from this plant, along
AML cell differentiation by activating the PKC/ERK with five known terpenoids. These compounds
signaling pathway and inducting ROS. In a word, were elucidated as vibsansuspenside A (3) and
these results demonstrated vibsanol A (16) could vibsansuspenside B (4), 23-hydroxy-3-oxo-urs-12-
enhance differentiation when combined with all- en-28-oic acid (124), cyperenolacid (5), spathulenol
trans retinoic acid in AML cells [47]. (Fig. 12) (6), and loliolide (1). With the exception of
Moreover, through network pharmacology, loliolide (1) and 23-hydroxy-3-oxo-urs-12-en-28-
bioinformatics analysis and molecular biology oic acid (124), they all showed neuroprotective
experiments, vibsanol C (37) was proved to have effects on H 2 O 2 -induced damage in SH-SY5Y
significant cytotoxicity against lung cancer A549 cells. Among them, 20-hydroxy-3-oxolup-28-oic
cell line. It also inhibited A549 cell lines via acid (109) exhibited the strongest neuroprotective
inhibition the EGFR and subsequent inactivation of effect [49].
282
A review on chemical constituents and bioactivities of Viburnum odoratissimum / Asian
Journal of Traditional Medicines, 2020, 15(5)
283
A review on chemical constituents and bioactivities of Viburnum odoratissimum / Asian
Journal of Traditional Medicines, 2020, 15(5)
284
A review on chemical constituents and bioactivities of Viburnum odoratissimum / Asian
Journal of Traditional Medicines, 2020, 15(5)
and the in-depth study on their mechanism is far [7] El-Gamal AA, Wang SK, Duh CY. New diterpenoids
from enough. There is no doubt that the research from Viburnum awabuki. J Nat Prod, 2004, 67333-
on the plant is still promising. Therefore, we 67336.
summarized the current research status and revealed [8] Kubo M, Chen IS, Fukuyama Y. Vibsane-type
that V. odoratissimum possesses strong potential Diterpenes from Taiwanese Viburnum odoratissimum.
a source of new drugs, in order to provide novel Chem & Pharm Bull, 2001, 49: 242-245.
insights into further study and development of this [9] He J, Peng LY, Tu L, et al. Vibsane-type diterpenes
plant. from leaves and twigs of Viburnum odoratissimum.
Fitoterapia, 2016, 109: 224-229.
Conflict of interest [10] Shen YC, Prakash CV, Wang LT, et al. New vibsane
diterpenes and lupane triterpenes from Viburnum
The authors have declared that there is no odoratissimum. J Nat Prod, 2002, 65: 1052-1055.
conflict of interest. [11] Kubo M, Nakai M, Harada K, et al. Structure of seven
new vibsane-type diterpenoids from Viburnum awabuki.
Acknowledgments Tetrahedron, 2019, 75: 2379-2384.
[12] Li FJ, Yu JH, Wang GC, et al. Diterpenes and lignans
This work was supported by National Natural from Viburnum odoratissimum var. odoratissimum. J
Science Foundation of China [Grant No. 81703385]. Asian Nat Prod Res, 2015, 17: 475-481.
[13] Fukuyama Y, Minami H, Matsuo A, et al. Seven-
References membered vibsane-type diterpenes with a 5, 10-cis
relationship from Viburnum awabuki. Chem & Pharm
[1] Liu J, Zhou WB, Cong YW, et al. Chemistry and Bull, 2002, 50: 368-371.
biological activities of Viburnum odoratissimum. Acta [14] Shen YC, Lin CL, Chen SC, et al. Vibsane diterpenoids
Pharm. Sin, 2013, 48: 325-332. from the leaves and flowers of Viburnum odoratissimum.
[2] Fukuyama Y, Kubo M. Chemical diversity of vibsane- J Nat Prod, 2004, 67: 74-77.
type diterpenoids. Curr Top Phyto, 2011, 43: 39-53. [15] Minami H, Anzaki S, Kubo M, et al. Structures of new
[3] Beechan CM, Djerassi C, Eggert H. The sesquiterpenes seven-membered ring vibsane-type diterpenes isolated
from the soft coral Sinularia mayi. Tetrahedron, 1978, from leaves of Viburnum awabuki. Chem & Pharm Bull,
34: 2503-2508. 1998, 46: 1194-1198.
[4] Marino SD, Borbone N, Gala F, et al. New constituents [16] Fukuyama Y, Minami H, Kagawa M, et al. Chemical
of sweet Capsicum annuum L. fruits and evaluation of conversion of vibsanin C to vibsanin E and structure
their biological activity. J Agric Food Chem, 2006, 54: of 3-hydroxyvibsanin E from viburnum awabuki. J Nat
7508-7516. Prod, 1999, 62: 337-339.
[5] Marino SD, Borbone N, Gala F, et al. Isolation and [17] Fukuyama Y, Morisaki M, Minoshima Y, et al.
Absolute Structures of the Neolignan Glycosides Cyclovibsanins, Unprecedented Seven-Membered
with the Enantimetric Aglycones from the Leaves of Vibsane-Type Diterpenes from Viburnum awabuki. Lett
Viburnum awabuki K. Koch. Chem & Pharm Bull, 1996, Org Chem, 2004, 1: 189-193.
44: 1122-1123. [18] Fukuyama Y, Kubo M, Fuji T, et al. Structures of
[6] Kawazu K. Isolation of vibsanines A, B, C, D, E and furanovibsanins A−G from Viburnum awabuki.
F from Viburnum odoratissimum. Agric & Biol Chem, Tetrahedron Lett, 2002, 58: 10033-10041.
1980, 44: 1367-1372. [19] Duh CY, EL-Gamal AA, Wang SK. Vibsanin O, a novel
285
A review on chemical constituents and bioactivities of Viburnum odoratissimum / Asian
Journal of Traditional Medicines, 2020, 15(5)
diterpenoid from Viburnum awabuki. Tetrahedron Lett, Hydroperoxylated guaiane-type sesquiterpenes from
2003, 44: 9321-9322. Viburnum awabuki. Phytochemistry, 1996, 42: 741-746.
[20] Kubo M, Chen IS, Minami H, et al. Aldovibsanins, Enol [32] Ma JZ, Yang XW, Zhang JJ, et al. Sterols and Terpenoids
Ester Free Vibsane-Type Diterpenes from Viburnum from Viburnum odoratissimum. Natur Prod & Bioprosp,
Odoratissimum. Chem & Pharm Bull, 1999, 47: 2014, 4: 175-180.
295-296. [33] Li FJ, Yu JH, Wang GC, et al. Diterpenes and lignans
[21] F u k u y a m a Y, M i n a m i H , Ta k e u c h i K , e t a l . from Viburnum odoratissimum var. odoratissimum. J
Neovibsanines A and B, Unprecedented Diterpenes from Asian Nat Prod Res, 2015, 17: 475-481.
Viburnum awabuki. Tetrahedron Lett, 1996, 37: 6767- [34] Zhang W, Lou HX, Li GY, et al. A new triterpenoid from
6770. Entodon okamurae broth. J Asian Nat Prod Res, 2003, 5:
[22] Fukuyama Y, Kubo M, Minami H, et al. Rearranged 189-195.
vibsanetype diterpenes from Viburnum awabuki and [35] Li JT, Yin BL, Liu Y, et al. Mono-aromatic constituents
photochemical reaction of vibsanin B. Chem & Pharm of Dendrobium longicornu. Chem Nat Compd, 2009, 45:
Bull, 2005, 53: 72-80. 234-236.
[23] Kubo M, Minami H, Hayashi E, et al. Neovibsanin C, [36] Zhu QF Qi, YY, Zhang ZJ, et al. Vibsane-type
a macrocyclic peroxide-containing neovibsane-type diterpenoids from Viburnum odoratissimum and their
diterpene from Viburnum awabuki. Tetrahedron Lett, cytotoxic and HSP90 inhibitory activities. Chem&
1999, 40: 6261-6265. Biodivers. 2018, 15: e1800049.
[24] F u k u y a m a Y, M i n a m i H , Ya m a m o t o I , e t a l . [37] Takao KI, Tsunoda K, Kurisu T, et al. Total Synthesis of
Neovibsanins H and I, novel diterpenes from Viburnum (+)-Vibsanin A. Org Lett, 2015, 17: 756-759.
awabuki. Chem & Pharm Bull, 1998. [38] Schwartz BD, Denton JR, Davies HM, et al. Total
[25] Kubo M, Fujii T, Hioki H, et al. Spirovibsanin A, an Synthesis of (±)-Vibsanin E. Aust J Chem, 2009, 62:
unprecedented vibsane-type 18-norditerpene from 980-982.
Viburnum awabuki. Tetrahedron Lett, 2010, 42: [39] Mak JY, Williams CM. Key achievements in the total
1081-1083. synthesis of vibsane-type diterpenoids. Nat Prod Rep,
[26] Kubo M, Minoshima Y, Arimoto D, et al. Acetal-bearing 2012, 43: 440-448.
rearranged vibsane-type diterpenoids from Viburnum [40] Kubo M, Kishimoto Y, Harada K, et al. NGF-
awabuki. Heterocycles, 2009, 77: 539. potentiating vibsane-type diterpenoids from Viburnum
[27] Kuroyanagi M, Shiotsu M, Ebihara T, et al. Chemical sieboldii. Bioorg & Med Chem lett, 2010, 20: 2566-
studies on Viburnum awabuki K. Koch. Chem & Pharm 2571.
Bull, 1986, 34: 4012-4017. [41] Fukuyama Y, Minami H, Kagawa M, et al. Chemical
[28] El G, Ali A. Cytotoxic lupane-, secolupane-, and conversion of vibsanin C to vibsanin E and structure
oleanane-type triterpenes from, Viburnum awabuki. Nat of 3-hydroxyvibsanin E from viburnum awabuki. J Nat
Prod Lett, 2008, 2: 191-197. Prod, 1999, 62: 337-339.
[29] K a g a w a M , M i n a m i H , N a k a h a r a M , e t a l . [42] Miura K, Matsuki W, Ogura A, et al. Identification of
Oleanane-type triterpenes from Viburnum awabuki. vibsanin A analog as a novel HSP90 inhibitor. Bioorg &
Phytochemistry, 1998, 47: 1337-1341. Med Chem, 2020, 28: 115253.
[30] Shen YC, Prakash CV, Wang LT, et al. New triterpenoid [43] Shao LD, Su J, Ye BX, et al. Design, Synthesis, and
fatty acid esters from the small twigs of Viburnum Biological Activities of Vibsanin B Derivatives: A New
odoratissimum. Jo Chin Chem Soc, 2003, 50: 297-302. Class of HSP90 C Terminal Inhibitors. J Med Chem,
[31] F u k u y a m a Y, M i n a m i H , I c h i k a w a R , e t a l . 2017, 60: 9053-9066.
286
A review on chemical constituents and bioactivities of Viburnum odoratissimum / Asian
Journal of Traditional Medicines, 2020, 15(5)
[44] Ge YC, Zhang HJ, Lei JX, et al. Chemical Constituents [48] Zhang YY, Chen JJ, Li DQ, et al. Network pharmacology
of Viburnum odoratissimum and Their Cytotoxic uncovers anti-cancer activity of vibsane-type diterpenes
Activities. Chem Nat Compd, 2018, 54: 1-3. from Viburnum odoratissimum. Nat Prod Res, 2019, 11:
[45] Matsuki W, Miyazaki S, Yoshida K, et al. Synthesis and 1-4.
evaluation of biological activities of vibsanin A analogs. [49] Zhang Y, Zhou WY, Song XY, et al. Neuroprotective
Bioorg & Med Chem Lett, 2017, 27: 4536-4539. terpenoids from the leaves of Viburnum odoratissimum.
[46] Shen X, Xing S, Zhang L, et al. Vibsanin A sensitizes Nat Prod Res. 2020. 34: 1352-1359.
human acute myeloid leukemia cells to tyrosine kinase [50] Ye B X , D e n g X , S h a o L D , e t a l . Vi b s a n i n B
inhibitor-induced myeloid differentiation via activation Preferentially Targets HSP90β, Inhibits Interstitial
of PKC and upregulation of Lyn. Biochem Biophys Res Leukocyte Migration, and Ameliorates Experimental
Commun, 2018. 502: 110-115. Autoimmune Encephalomyelitis. J Immunol, 2015, 194:
[47] Yang M, Xing S, Ou HL, et al. Vibsanol A induces 4489-4497.
differentiation of acute myeloid leukemia cells via [51] Su JC. Studies on the chemical constituents of Viburnum
activation of the PKC signaling pathway and induction odoratissimum Ker. Acta Bot Sin. 1983, 25: 91-92.
of ROS. Leukemia and Lymphoma, 2018, 59: 1-9.
287